In prior work more than two thousand PD patients (including 198 GBA-PD patients) with 20,868 longitudinal study visits2 were needed to uncover a significant link between GBA mutations and longitudinal decline in clinical cognitive assessments due to variation in clinical assessments. The gene discussed is GBA1; the disease is Parkinson disease.